The committee reviewed existing and in-progress clinical research before proceeding to discussion. In discussing the literature, the Committee emphasized there is a large imbalance between studies performed on animals (90 percent) and studies performed on humans (10 percent). The discrepancy makes it difficult to draw conclusions about risk levels for anesthesia in children.
Read the ASA release on the FDA meeting on pediatric anesthesia.
Read more on anesthesia:
–Changes to Epidural Doses Allow Movement Without Pain
–Anesthesiologist on the Move: Dr. Suwarna Bhide Deoskar Joins Essentia Health
–Drug Shortages Force California Facilities to Look for Alternatives
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.